Skip to main content
Caplight Logo









LungHealth MedTech

LungHealth MedTech

Private
ShanghaiHealthcare & Life Scienceshttps://lunghealth.cn

Last Round

Series C

Dec 12, 2023

Total Funding Raised

$29.4M

Company Overview

LungHealth MedTech is a medical technology company that develops robotic-assisted bronchoscopy systems and minimally invasive diagnostic and therapeutic solutions for early lung cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

robotic bronchoscopysurgical roboticsmedical AIlung cancer detectionminimally invasive surgerybronchoscopic navigationsurgical robotAI surgical assistantmedtechremote surgery5G remote controlperipheral lung nodulesendoscopic surgerysurgical navigationdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LungHealth MedTech Comparables

Compare LungHealth MedTech with similar companies based on industry and business-model similarity.

LungHealth MedTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noah Medical
83%
Beijing Surgerii Robotics
81%
Broncus Medical
79%

LungHealth MedTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 12, 2023
Series BApr 19, 2022
Series AJul 1, 2017

LungHealth MedTech Investors

Notable investors and investment history

LungHealth MedTech investors
InvestorRounds
Tailong InvestmentSeries B
Yunion Health InvestmentsSeries B
Tigeryeah CapitalSeries A
协立投资Series B, Series A
Jiuyo Capital ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 12, 2023

    $14M round led by Jiuyo Capital Management

  • Apr 19, 2022

    $16M round led by Yunion Health Investments.

LungHealth MedTech Filings

Explore SEC and related filing metadata, where available.

LungHealth MedTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LungHealth MedTech's valuation, stock price, and market status.

Is LungHealth MedTech a public or private company?

LungHealth MedTech is a private company.

What is the current stock price of LungHealth MedTech?

LungHealth MedTech is a private company, so its shares have no public market price. Caplight tracks LungHealth MedTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is LungHealth MedTech worth (valuation)?

Valuation information for LungHealth MedTech is not publicly available.

Can I buy LungHealth MedTech stock?

LungHealth MedTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was LungHealth MedTech's last funding round?

LungHealth MedTech's most recent funding round was Series C on December 12, 2023.

Who are the main investors in LungHealth MedTech?

Key investors in LungHealth MedTech include Yunion Health Investments, Jiuyo Capital Management.

Will LungHealth MedTech IPO soon?

No public IPO plans have been announced for LungHealth MedTech.

How can I track LungHealth MedTech secondary market activity?

Caplight tracks bids, offers, and trades in LungHealth MedTech's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Year Founded2015
Last FundingDec 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?